Garlic Powder in the Treatment of Moderate Hyperlipidaemia: A Controlled Trial and Meta-Analysis
Open accessThe DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: To determine the effect of 900 mg/day of dried garlic powder (standardised to 1.3% allicin) in reducing total cholesterol. DESIGN: Double-blind, randomised six-month parallel trial. SUBJECTS: 115 individuals with a repeat total cholesterol concentration of 6.0-8.5 mmol/l and low-density lipoprotein (LDL) cholesterol of 3.5 mmol/l or above after six weeks of dietary advice. INTERVENTION: The active treatment group received dried garlic tablets (standardised to 1.3% allicin) at a dosage of 300 mg three times daily. The control group received a matching placebo. OUTCOME MEASURES: Primary end-point: total cholesterol concentration; secondary end-points: concentrations of LDL and high-density lipoprotein cholesterol, apolipoproteins (apo) A1 and B, and triglycerides. RESULTS: There were no significant differences between the groups receiving garlic and placebo in the mean concentrations of serum lipids, lipoproteins or apo A1 or B, by analysis either on intention-to-treat or treatment received. In a meta-analysis which included the results from this trial, garlic was associated with a mean reduction in total cholesterol of -0.65 mmol/l (95% confidence intervals: -0.53 to -0.76). CONCLUSIONS: In this trial, garlic was less effective in reducing total cholesterol than suggested by previous meta-analyses. Possible explanations are publication bias, overestimation of treatment effects in trials with inadequate concealment of treatment allocation, or a type 2 error. We conclude that meta-analyses should be interpreted critically and with particular caution if the constituent trials are small.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Publication bias in clinical research
Easterbrook, P. J., Gopalan, R., Berlin, J. A., & Matthews, D. R. (1991) · The Lancet · doi:10.1016/0140-6736(91)90201-y · Cited by 3,109
Cumulative Meta-Analysis of Therapeutic Trials for Myocardial Infarction
Lau, J., Antman, E. M., Jimenez-Silva, J., Kupelnick, B., Mosteller, F., & Chalmers, T. C. (1992) · New England Journal of Medicine · doi:10.1056/nejm199207233270406 · Cited by 1,140
Egger, M., & Smith, G. D. (1995) · BMJ · doi:10.1136/bmj.310.6982.752 · Cited by 508
Cited by
Intake of Garlic and Its Bioactive Components
Amagase, H., Petesch, B. L., Matsuura, H., Kasuga, S., & Itakura, Y. (2001) · The Journal of Nutrition · doi:10.1093/jn/131.3.955s · Cited by 1,049
Health benefits of herbs and spices: the past, the present, the future
Tapsell, L. C., Hemphill, I., Cobiac, L., Sullivan, D. R., Fenech, M., Patch, C. S., Roodenrys, S., Keogh, J. B., Clifton, P. M., Williams, P. G., et al. (2006) · Medical Journal of Australia · doi:10.5694/j.1326-5377.2006.tb00548.x · Cited by 988
Biological properties of onions and garlic
CORZOMARTINEZ, M., CORZO, N., & VILLAMIEL, M. (2007) · Trends in Food Science & Technology · doi:10.1016/j.tifs.2007.07.011 · Cited by 810
Clarifying the real bioactive constituents of garlic
Amagase, H. (2006) · The Journal of Nutrition · doi:10.1093/jn/136.3.716s · Cited by 680
Effect of garlic on cardiovascular disorders: a review
Banerjee, S. K., & Maulik, S. K. (2002) · Nutrition Journal · doi:10.1186/1475-2891-1-4 · Cited by 627
Metadata
- Authors
- Neil, H. A. W., Silagy, C. A., Lancaster, T., Hodgeman, J., Vos, K., Moore, J. W., Jones, L., Cahill, J., & Fowler, G. H.
- Venue
- Journal of the Royal College of Physicians of London
- Publisher
- Elsevier BV
- Published
- 1996-07
- Volume
- 30
- Issue
- 4
- Pages
- 329-334
- ISSN
- 0035-8819 (ISSN-L)
- OpenAlex
- W139259995
- Cited by
- 133
- References
- 3
- FWCI
- 9.03
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Garlic Powder in the Treatment of Moderate Hyperlipidaemia: A Controlled Trial and Meta-Analysis. https://app.cochat.ai/papers/10.1016/s0035-8819(25)00368-x
- The paper
- Neil, H. A. W., Silagy, C. A., Lancaster, T., Hodgeman, J., Vos, K., Moore, J. W., Jones, L., Cahill, J., & Fowler, G. H. (1996). Garlic Powder in the Treatment of Moderate Hyperlipidaemia: A Controlled Trial and Meta-Analysis. Journal of the Royal College of Physicians of London. https://doi.org/10.1016/s0035-8819(25)00368-x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.